Company overview
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.
News Center
-
06-142020The second general meeting of shareholders of ImmuneOnco was successfully heldOn the morning of June 11, 2020, the second general meeting of shareholders of ImmuneOnco was held in the meeting room o......See details
-
09-012020The IMM01 project patent of ImmuneOnco was authorized by the patent offices of the United States and JapanImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. announced that theIMM01project was recently authorized by the U.S. Pa......See details
-
05-262020ImmuneOnco appointed Mr. Huang Cheng as the vice general manager in charge of clinical medicine departmentImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.announced the appointment of Mr. Huang Cheng as the vice general manag......See details